MedPath

Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols

Not Applicable
Completed
Conditions
Mildly Hypercholesterolemic Subjects
Interventions
Other: 2- Low fat drinkable fermented dairy product without plant sterols (control)
Other: 1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit
Registration Number
NCT01571869
Lead Sponsor
Danone Research
Brief Summary

The objective of this study is to compare efficacy of a plant sterol enriched yogurt given at different moments of the day in lowering blood cholesterol of hypercholesterolemic.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • male and post-menopausal female aged 40-80 years;
  • BMI between 22 and 32 kg/m2,
  • Non-smoker, Stabilized LDL-c over 3.0 mmol/L,
  • Not taking any medication known to affect lipid metabolism for at least the previous 3 month period,
  • Agree to follow the dietary recommendations in the context of their hypercholesterolemia,
  • Have to give written consent to take part in the study
Exclusion Criteria
  • Thyroid disease, diabetes mellitus, kidney disease or liver disease, Hypertension (95<SBP>140 mmHg and/or 45<DBP>90 mmHg),
  • Previous history of symptomatic vascular disease, TG level > 2,8 g/l,
  • History of metabolic or gastrointestinal disease with the exception of appendicectomy,
  • Consumption of large amounts of alcohol,
  • Having undergone general anesthesia in the month prior to pre-selection,
  • Receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters,
  • Having serious or acute disease likely to influence study results or involved in life time,
  • Presenting allergy or hypersensitivity to milk proteins, or refusing to consume them,
  • Refusing to stop his/her consumption of enriched plant sterol trade products during the study,
  • In a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject,
  • For female subjects: likely to change her hormonal substitutive treatment,
  • Currently in an exclusion period following participation in another clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
2 = Control product2- Low fat drinkable fermented dairy product without plant sterols (control)-
1 = Tested product1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

McGill University

🇨🇦

Ste-anne-de-bellevue, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath